We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

90 hedge funds and large institutions have $167M invested in VanEck Biotech ETF in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

8% more funds holding

Funds holding: 83 → 90 (+7)

2% less call options, than puts

Call options by funds: $4.19M | Put options by funds: $4.28M

21% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 29

21.1% less ownership

Funds ownership: 45.23% → 24.14% (-21%)

43% less capital invested

Capital invested by funds: $294M → $167M (-$127M)

Holders
90
Holders Change
+7
Holders Change %
+8.43%
% of All Funds
2.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
23
Reduced
29
Closed
9
Calls
$4.19M
Puts
$4.28M
Net Calls
-$87K
Net Calls Change
+$2.9M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.67M
2
LPL Financial
LPL Financial
California
+$3.92M
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.91M
4
Citadel Advisors
Citadel Advisors
Florida
+$3.87M
5
BPC
Banque Pictet & Cie
Switzerland
+$2.35M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$147M
2
CS
Credit Suisse
Switzerland
-$13.6M
3
TRCT
Tower Research Capital (TRC)
New York
-$3.49M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.08M
5
HF
HRT Financial
New York
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
AFG
26
Albion Financial Group
Utah
$1.62M +$21.9K +179 +1%
Bank of America
27
Bank of America
North Carolina
$1.6M +$143K +1,171 +10%
VKH
28
Virtu KCG Holdings
New York
$1.5M -$677K -5,523 -32%
GP
29
GLG Partners
United Kingdom
$1.38M -$1.3M -10,620 -49%
WJA
30
Williams Jones & Associates
New York
$1.28M -$276K -2,250 -18%
EDRS
31
Edmond de Rothschild (Suisse)
Switzerland
$1.25M -$307K -2,505 -20%
Stifel Financial
32
Stifel Financial
Missouri
$1.11M +$63.7K +520 +6%
IA
33
IFP Advisors
Florida
$1M +$964K +7,873 New
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$930K -$3.08M -25,118 -77%
NPC
35
National Planning Corporation
California
$909K -$373K -3,043 -25%
TRCT
36
Tower Research Capital (TRC)
New York
$872K -$3.49M -28,466 -81%
HSBC Holdings
37
HSBC Holdings
United Kingdom
$790K -$27.6K -225 -3%
GJIC
38
Gamble Jones Investment Counsel
California
$762K – – –
AIG
39
American International Group
New York
$752K -$141K -1,155 -16%
HighTower Advisors
40
HighTower Advisors
Illinois
$627K -$58.1K -474 -9%
CWM
41
Concert Wealth Management
California
$623K +$603K +4,920 New
SG Americas Securities
42
SG Americas Securities
New York
$561K +$343K +2,800 +173%
Millennium Management
43
Millennium Management
New York
$502K -$240K -1,963 -33%
IAMOG
44
Investors Asset Management of Georgia
Georgia
$470K – – –
CFMC
45
Curbstone Financial Management Corp
New Hampshire
$438K +$153K +1,250 +57%
Cambridge Investment Research Advisors
46
Cambridge Investment Research Advisors
Iowa
$405K +$490 +4 +0.1%
First Manhattan
47
First Manhattan
New York
$380K – – –
CCT
48
Country Club Trust
Missouri
$371K +$358K +2,925 New
FAAS
49
First Allied Advisory Services
California
$360K – – –
PAG
50
Private Advisor Group
New Jersey
$338K +$6.74K +55 +2%
1
2
3 4

BBH Hedge Fund Activity: Q4 2015 in Review

90 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2015, worth a combined $167M — down 43% from $294M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 9 closed out — a net gain of 7 holders — while 23 added to existing stakes and 29 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.67M. The largest seller was Goldman Sachs, cutting an estimated $147M.

  • 90 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2015, up from 83 in Q3 2015.
  • Funds reported $167M of VanEck Biotech ETF stock for Q4 2015, down 43% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q4 2015 and 9 closed out, a net change of +7 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2015 was Morgan Stanley, an estimated $5.67M added.
  • The largest VanEck Biotech ETF seller in Q4 2015 was Goldman Sachs, an estimated $147M sold.

Based on aggregated 13F filings for Q4 2015.